Drugs Made In America Acquisition Corp. · NASDAQ:DMAA

Karpus Management, Inc. reported a 6.93% stake in Drugs Made In America Acquisition Corp. (Schedule 13G)

Event Mar 31, 2025 · Filed May 14, 2025

Karpus Management, Inc. reported a 6.93% stake in Drugs Made In America Acquisition Corp., 2,324,034 shares, as a passive investor on Mar 31, 2025. Filed May 14, 2025 (Schedule 13G).

Stake
6.93%
Shares
2,324,034
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
KARPUS MANAGEMENT, INC.6.93%2,324,034

Source

View original at SEC

Related